| 摘要: |
| 目的 通过研究五环三萜类新型化合物对癌细胞的抑制力,从而发现新型抗癌药物。方法 以天然产物熊果酸(UA)为先导化合物,对C-2位氢、C-3位羟基和C-28位羧基以及A环进行结构改造,设计并合成了8个新的熊果酸衍生物。结果 采用MTT法对目标化合物进行初步的体外抗肿瘤活性研究。该类化合物对HeLa、HepG2和BGC-823细胞增殖具有一定程度的抑制作用,其中化合物I3对HeLa、HepG2和BGC-823细胞表现出很强的抑制活性。结论 该化合物对于上述细胞的抑制作用明显高于已上市药物吉非替尼,值得进一步研究。 |
| 关键词: 熊果酸衍生物 抗肿瘤活性 抑制剂 |
| DOI:10.13506/j.cnki.jpr.2016.09.005 |
| 基金项目: |
|
|
|
| Synthesis and anti-tumor activity of ursolic acid derivatives |
| MENG Yanqiu,LI Sizhu |
| (Department of Pharmaceutical Engineering,Shenyang University of Chemical Technology,Shenyang 110142, China) |
| Abstract: |
| Objective To study the inhibitory ability of pentacyclic triterpenoids novel compounds to cancer cells,and thus find new anticancer drugs.Methods Structure of natural product-ursolic acid was modified for increasing its antitumor activity.Eight new derivatives of ursolic acid were designed and synthesized by the structure modified at C-2 hydrogen,C-3 hydroxyl group,C-28 carboxy group and ring A.Results The antitumor activities of target compounds were evaluated by MTT assay.The results indicated that all the compounds had a degree of inhibition on cell proliferation of HeLa,HepG2 and BGC-823 cells.Compound I3 showed strong inhibitory activity to HeLa,HepG2 and BGC-823 cells.Conclusion The compounds showed strong inhibitory activity on these three kinds of tumor cells,significantly higher than the listed drug Gefitinib,and were worth to be intensively studied further. |
| Key words: Ursolic acid derivatives Antitumor activity Inhibitor |